uniQure N.V. (QURE)
Market: NASD |
Currency: USD
Address: Paasheuvelweg 25
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Show more
📈 uniQure N.V. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$35.50
-
Upside/Downside from Analyst Target:
135.10%
-
Broker Call:
24
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
0-10%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for uniQure N.V.
| Date | Reported EPS |
|---|
| 2026-02-25 (estimated upcoming) | - |
| 2025-11-05 (estimated upcoming) | - |
| 2025-07-31 (estimated upcoming) | - |
| 2025-05-09 | - |
| 2025-05-09 | -0.82 |
| 2025-02-27 | -1.52 |
| 2024-11-05 | -0.91 |
| 2024-08-01 | -1.16 |
| 2024-07-31 | -1.16 |
| 2024-05-07 | -1.36 |
| 2024-05-06 | -1.36 |
| 2024-02-28 | -1.53 |
| 2024-02-27 | -1.53 |
| 2023-11-07 | -1.88 |
| 2023-11-06 | -1.88 |
| 2023-08-01 | -1.44 |
| 2023-07-31 | -1.44 |
| 2023-05-09 | -1.63 |
| 2023-05-08 | -1.63 |
| 2023-02-27 | 0.15 |
| 2023-02-26 | 0.15 |
| 2022-11-02 | -1.02 |
| 2022-11-01 | -1.02 |
| 2022-08-08 | -0.84 |
| 2022-08-07 | -0.84 |
| 2022-05-02 | -1 |
| 2022-05-01 | -1 |
| 2022-02-25 | 0.17 |
| 2022-02-24 | 0.17 |
| 2021-10-25 | -0.79 |
| 2021-10-24 | -0.79 |
| 2021-07-26 | 8.51 |
| 2021-07-25 | 8.51 |
| 2021-05-10 | -0.91 |
| 2021-05-09 | -0.91 |
| 2021-03-01 | -0.01 |
| 2021-02-28 | -0.01 |
| 2020-10-27 | -1.21 |
| 2020-10-26 | -1.21 |
| 2020-07-30 | -0.96 |
| 2020-07-29 | -0.96 |
| 2020-04-29 | -0.63 |
| 2020-04-28 | -0.63 |
| 2020-03-02 | -0.96 |
| 2020-03-01 | -0.96 |
| 2019-10-27 | -0.58 |
| 2019-07-28 | -0.83 |
| 2019-04-28 | -0.74 |
| 2019-02-27 | -0.59 |
| 2018-11-05 | -0.59 |
| 2018-08-07 | -0.57 |
| 2018-04-29 | -0.59 |
| 2018-03-13 | -0.91 |
| 2017-10-31 | -0.4 |
| 2017-08-07 | -0.75 |
| 2017-05-08 | -0.75 |
| 2017-03-14 | -0.51 |
| 2016-11-21 | -0.54 |
| 2016-08-24 | -0.77 |
| 2016-05-30 | -0.83 |
| 2016-04-03 | -0.58 |
| 2015-11-29 | -1.08 |
| 2015-08-26 | -0.87 |
| 2015-06-10 | -0.78 |
| 2015-04-05 | -0.77 |
| 2014-11-30 | -0.68 |
| 2014-09-01 | -0.7 |
| 2014-06-05 | -0.71 |
📰 Related News & Research
No related articles found for "uniqure nv".
